Vaxcyte, Inc. (PCVX) Stock News & Chart | StockAdder

(PCVX)

Vaxcyte, Inc.

Stock chart and latest news for Vaxcyte, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Vaxcyte, Inc. News

PRO

Stock Traders Daily

How Vaxcyte Inc. (PCVX) Affects Rotational Strategy Timing

Apr 11, 2026 Stock Titan

Vaxcyte (PCVX) finance chief sells 3,000 shares after option exercise

Apr 8, 2026 Yahoo Finance

Vaxcyte Inc. (PCVX) Confident of Topline Data in Pneumococcal Vaccine Trials

Feb 19, 2026 Investing.com

Vaxcyte prices $550 million public offering of common stock

Jan 29, 2026 Yahoo Finance

Vaxcyte, Inc. (PCVX) Makes Strides on Pneumonia Treatment, Plots Coverage Extension

Dec 11, 2025 Stock Titan

Vaxcyte management joins Needham virtual healthcare event Apr. 14

Apr 7, 2026 Yahoo Finance

What Makes Vaxcyte (PCVX) So Attractive

Dec 22, 2025 Stock Titan

Vaxcyte (PCVX) COO sells 2,250 shares in planned Rule 10b5-1 trades

Apr 3, 2026 Yahoo Finance

Vaxcyte (PCVX) $632.5M Stock Offering Follows Bullish Cantor Fitzgerald Rating

Feb 18, 2026 Stock Titan

PCVX SEC Filings - Vaxcyte, Inc. 10-K, 10-Q, 8-K Forms

Apr 2, 2026 Yahoo Finance

Evercore ISI Rates Vaxcyte Inc. (PCVX) as an Overweight Following CDC Changes to Childhood Vaccination Recommendations

Jan 26, 2026 Stock Titan

Elvia Cowan registers 3,000-share sale (PCVX) after option exercise